UK markets close in 2 hours 9 minutes

ECO Animal Health Group plc (EAH.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
96.50-1.50 (-1.53%)
As of 12:59PM BST. Market open.

ECO Animal Health Group plc

78 Coombe Road
New Malden KT3 4QS
United Kingdom
44 20 8 336 2900
https://www.ecoanimalhealthgroupplc.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 234

Key executives

NameTitlePayExercisedYear born
Mr. David Charles HallasCEO & Director491kN/A1964
Mr. Christopher Wilks ACA, BSc, F.C.A.CFO, Finance Director, Secretary & Director332kN/A1964
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, mange, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. ECO Animal Health Group plc was founded in 1972 and is based in London, the United Kingdom.

Corporate governance

ECO Animal Health Group plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.